Certara

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Meta Platforms, DraftKings, Costco, Micron Technology, Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Intraday Update

Markets

Movers

Trading Ideas

BMEA

CERT

DADA

ESBA

IONQ

MNSO

RKLB

UXIN

IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday

Capital gains taxation

Fintech news covering the emerging Financial Technology services sector

Fintech

Government

Politics

Tech

Personal Finance

FINX

INTU

New IRS program launching for free tax filing could affect tax prep companies like H&amp;R Block and Intuit. Market share drop could impact ETFs.

Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies

Penny Stocks

Small Cap

AMBI

CABA

CNEY

CYAD

ESPR

EVCM

FEMY

FFWM

FLNT

GNLX

GOSS

HNST

LEGH

LIPO

LPSN

LXEH

LYLT

MGNX

MLEC

MOMO

NCRA

NWPX

PACW

PATH

PRTK

PTRA

SNCE

TBLT

THMO

TITN

VGAS

VORB

WEJO

Gainers


	Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis.


Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Certara Inc

CertiK

CERTIVE SOLUTIONS INC by Certive Solutions, Inc.

Certive Solutions Inc

Management

Press Releases

MaxCyte Appoints Cynthia Collins to its Board of Directors

Certara Appoints John Reynders as New Independent Board Member

Certara to Participate in the Stephens Annual Investment Conference

Earnings

Certara Reports Third Quarter 2024 Financial Results

Analyst Ratings

General

Certara Showcases 2024 Research Wins With Over 100 Papers Published

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Certara Reports Fourth Quarter 2024 Financial Results

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

DMTKQ

MXCT

PSTX

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

CareCloud

Claritev Corporation Class A Common Stock

Claritev

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Schrodinger

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

Veeva Systems

VSee Health

Waystar Holding

Barclays

Stephens & Co.

Baird

Keybanc

Certicom Corp

Comments

Certara

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga